Variations of lymphocyte sub-populations in vulvar condylomata during therapy with beta-interferon. NLM AIDSLINE Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Variations of lymphocyte sub-populations in vulvar condylomata during therapy with beta-interferon.

Clin Exp Obstet Gynecol. 1992;19(2):120-4. Unique Identifier : AIDSLINE MED/93076417
Resta L; Troia M; Russo S; Colucci GA; Sabatini R; Loiudice L; Cagnazzo G; Institute of Pathological Anatomy, University of Bari, Italy.


Abstract: Several experiences induced us to consider genital HPV infection as an expression of a local immunodeficiency. The aim of our study was to research the effect of immunotherapy on the lymphocyte subpopulations and Langerhans cells in vulvar condyloma. Twenty women with persistent vulvar condylomata, treated with 2,000,000 IU/die of beta-interferon for 15 days, were submitted to vulvar biopsy before and 2-5 months after medical treatment. The frozen sections obtained were assayed with the following monoclonal antibodies: OKT4 (T helper lymphocytes), OKT8 (T suppressor lymphocytes), OKB7 (B lymphocytes) and S-100 protein (Langerhans cells). Using a morphometric evaluation, the average number of both intraepithelial and stromal lymphocyte subsets and of the intraepithelial Langerhans cells was assessed. In all the biopsies preceding the medical treatment we found a low number of T helper lymphocytes both in the epithelium and stroma, with inversion of T4/T8 lymphocyte ratio and rare presence of Langerhans cells. In patients with a good therapeutic response (50-100% of condyloma reduction) we observed an increase in intraepithelial T4 lymphocytes and a decrease in both intraepithelial and stromal T8 lymphocytes. In cases with persistent disease after therapy, the histological pattern was similar to that observed in the first biopsy, with the exception of a significant increase in the average number of Langerhans cells. Our data correlate the clinical response to the immunotherapy with the histology of lymphocyte subsets in the vulvar condylomata. The increase in Langerhans cells observed in patients with negative response may be interpreted with a probable inability of these cells to promote the immune reaction.
Keywords: Adult Antibodies, Monoclonal/DIAGNOSTIC USE Biopsy Comparative Study Condylomata Acuminata/IMMUNOLOGY/*THERAPY CD4-CD8 Ratio Female Human Injections, Intramuscular Interferon-beta/ADMINISTRATION & DOSAGE/*THERAPEUTIC USE *Lymphocyte Subsets Vulvar Neoplasms/IMMUNOLOGY/*THERAPY JOURNAL ARTICLEKWDadultantibodies,monoclonal/diagnosticusebiopsycomparativestudycondylomataacuminata/immunology/KWDtherapycd4-cd8ratiofemalehumaninjections,intramuscularinterferon-beta/administration&dosage/KWDtherapeuticuseKWDlymphocytesubsetsvulvarneoplasms/immunology/KWDtherapyjournalarticle
930330
M9331074

Copyright © 1993 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .